KeyBanc Starts Castle Biosciences (CSTL) at Overweight
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Price: $31.43 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 8
Join SI Premium – FREE
KeyBanc initiates coverage on Castle Biosciences (NASDAQ: CSTL) with a Overweight rating and a price target of $70.00.
For an analyst ratings summary and ratings history on Castle Biosciences click here. For more ratings news on Castle Biosciences click here.
Shares of Castle Biosciences closed at $51.70 yesterday.
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Piper Sandler Starts Unusual Machines (UMAC) at Overweight
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
